Fairvalue-Calculator Fairvalue-Calculator
EN DE

Breakthrough Chemistry, Inc (BKTH) Fair Value & Analysis

Industrials · US · Market cap $2.4M

Price$0.2922
Fair Value$0.2200
Upside-24.7%
Quality95/100
Evidence: Low Range $0.1600 – $0.2700

Fair value as of: Jun 24, 2026

Analysis

Breakthrough Chemistry, Inc (BKTH) currently trades at $0.2922, while our model-based Fair Value estimate is $0.2200 — implying the stock looks roughly 24.7% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Breakthrough Chemistry, Inc. develops compounds and formulations that defy the norms prevalent in chemical industries. The company's chemistry platform offers solutions for food security and spoilage reduction, natural resource conservation, personal hygiene, protective coatings, odor elimination, and chemical neutralization. Breakthrough Chemistry, Inc. was formerly known as Megola, Inc. and changed its name to Breakthrough Chemistry, Inc. in July 2025. The company is based in Bonita Springs, Florida.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Breakthrough Chemistry, Inc (BKTH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.2200 versus a price of $0.2922 — about −25% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BKTH?
Our 21-model fair value for Breakthrough Chemistry, Inc is $0.2200 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.2922.
What is the quality score of BKTH?
Breakthrough Chemistry, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.